Skip to Main Content
IVR Change Management Ideas Portal
Status Closed
Created by Carol McCullen
Created on Mar 15, 2023

Product Recognition for AREXVY [CR 334]

Add new product for recognition to the main IVR.


AREXVY is a new vaccine to prevent RSV- route to vaccine queue for HCP IVR path, and product for applicable paths e.g. - side effect, PQC etc.

Also recognize the term "RSV Vaccine" and route the same, noting that these are related terms for future reference.

Pronunciation attached.


Vanity number for HCP brand.com site - AREXVY - (1-877-ARE-XVY1) = 1-877-273-9891


Can release sooner than 5/3/23


Priority Medium
Contact Center(s) GRC
Start date Mar 17, 2023
Needed By May 3, 2023
Closure Date May 8, 2023
  • Attach files
  • Carol McCullen
    Reply
    |
    Apr 18, 2023

    4/18/23 - Eric to have TFN ready to be in production on 5/3/23, but cannot be in production until the product is FDA approved which should receive notification on 5/3/23. <The remainder of this comment belongs in a separate IDEA for the routing.> Once Carol notifies Eric/Christie of approval, the number needs to go into production ASAP on 5/4/23 for calls to be directed to the front of the IVR for HCP menu options and routing.

  • Stephen Keilholz
    Reply
    |
    Apr 8, 2023

    Status Notes

    3/24 Sent email requesting recording. Recording will be bundled with others.

    3.26 Audio received and now attached.

    4.14 Grammar file is done. Waiting on recordings - due back later today. Testing to be done on Monday.

    5-May-2023 - Work completed and request for closure sent to Carol.

    8-May-2023 - Closure approval received. See attachment.

  • Stephen Keilholz
    Reply
    |
    Apr 8, 2023

    Review Comments

    Awaiting audio file from Carol